Cytosorbents (CTSO) FCF Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -473.00 |
| 10 | Cytosorbents | 21.30 Mn | 16.89 Mn | 7.05 Mn | 727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 727.00 |
| Mar 31, 2026 | 2,651.00 |
| Dec 31, 2025 | -3,010.00 |
| Sep 30, 2025 | 301.00 |
| Jun 30, 2025 | 3,835.00 |
| Mar 31, 2025 | 1,449.00 |
| Dec 31, 2024 | 5,681.00 |
| Sep 30, 2024 | 2,873.00 |
| Jun 30, 2024 | 1,917.00 |
| Mar 31, 2024 | -2,134.00 |
| Dec 31, 2023 | -8,198.00 |
| Sep 30, 2023 | 9,352.00 |
| Jun 30, 2023 | 1,539.00 |
| Mar 31, 2023 | 6,869.00 |
| Dec 31, 2022 | 8,655.00 |
| Sep 30, 2022 | -12,273.00 |
| Jun 30, 2022 | -6,549.00 |
| Mar 31, 2022 | -7,543.00 |
| Dec 31, 2021 | -7,450.00 |
| Sep 30, 2021 | 344.00 |